Publications by authors named "Yin-Guang Cao"

The purpose of this study was to construct a Coxsackie virus A16 (CA16) mucosal vaccine and evaluate its ability to induce immune response. VP1 gene of CA16 was inserted into the genome of Bacillus subtilis via recombination and displayed on the surface of the spores. This Bacillus-based vaccine was used for intranasal immunization of mice and the serum antibody titer was determined by enzyme-linked immunosorbent assay (ELISA).

View Article and Find Full Text PDF

Unlabelled: This study was designed to investigate the inhibition activity of polysaccharide extract from Laminaria japonica against RSV. The polysaccharide from Laminaria japonica was isolated by ethanol precipitation. HEK293 cells were infected with RVS, and the antiviral activity of polysaccharide extract against RSV in host cells was tested.

View Article and Find Full Text PDF

Nasal respiratory epithelium is a ciliated pseudostratified columnar epithelium. The cellular components of nasal respiratory epithelium include ciliated cells, goblet cells, and basal cells. Until now, our knowledge in the development of nasal respiratory epithelium is still limited and the cellular mechanism of regeneration is still elusive.

View Article and Find Full Text PDF

A novel series of pyrazine-1,3-thiazine hybrid conjugates were synthesized in excellent yield. These derivatives were subsequently tested against human immunodeficiency virus (HIV-1); hemagglutinin type 1 and neuraminidase type 1-'influenza' A (H1N1) virus; enterovirus 71 (EV71); and coxsackievirus B3. The effect of these conjugates on the key enzymes responsible for the progression of these viral infections was also illustrated via enzyme-based assay, such as HIV-1 reverse transcriptase (RT) and neuraminidase, where entire tested molecules showed considerable inhibition.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how a chemical called 3-bromopyruvate affects cancer cells known as CD133+ U87 glioma cells, which are a type of brain tumor cells.
  • It found that 3-bromopyruvate makes these cancer cells smaller and stops them from growing, especially when used at a certain concentration after 48 hours.
  • The treatment also showed signs of damaging the cancer cells, like changes to their membranes and DNA, and it helps target these cells better than regular U87 cells.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the effects of survivin interference RNA (siRNA) on non-small cell lung cancer both in lab settings (in vitro) and in living organisms (in vivo).
  • Researchers used lentivirus to deliver siRNA into human lung cancer cells (A549) and assessed cell growth through specific assays, also injecting the siRNA into mouse tumors.
  • Results showed that siRNA treatment significantly reduced cancer cell growth and tumor size compared to control groups, demonstrating its potential as an effective therapy against lung cancer.
View Article and Find Full Text PDF